Topic
ST elevation
About: ST elevation is a research topic. Over the lifetime, 4135 publications have been published within this topic receiving 112999 citations. The topic is also known as: ST segment elevation.
Papers published on a yearly basis
1 / 2
Papers
TL;DR: Common clinical and ECG features define a distinct syndrome in this group of patients with recurrent episodes of aborted sudden death unexplainable by currently known diseases, not explainable by electrolyte disturbances, ischemia or structural heart disease.
3,378 citations
TL;DR: A substantial proportion of patients receiving fibrinolytic therapy for myocardial infarction with ST-segment elevation have inadequate reperfusion or reocclusion of the infarct-related artery, leading to an increased risk of complications and death as discussed by the authors.
Abstract: Background A substantial proportion of patients receiving fibrinolytic therapy for myocardial infarction with ST-segment elevation have inadequate reperfusion or reocclusion of the infarct-related artery, leading to an increased risk of complications and death. Methods We enrolled 3491 patients, 18 to 75 years of age, who presented within 12 hours after the onset of an ST-elevation myocardial infarction and randomly assigned them to receive clopidogrel (300-mg loading dose, followed by 75 mg once daily) or placebo. Patients received a fibrinolytic agent, aspirin, and when appropriate, heparin (dispensed according to body weight) and were scheduled to undergo angiography 48 to 192 hours after the start of study medication. The primary efficacy end point was a composite of an occluded infarct-related artery (defined by a Thrombolysis in Myocardial Infarction flow grade of 0 or 1) on angiography or death or recurrent myocardial infarction before angiography. Results The rates of the primary efficacy end poin...
1,897 citations
TL;DR: The management of acute myocardial infarction continues to undergo major changes as discussed by the authors, and good practice should be based on sound evidence derived from well-conducted clinical trials.
Abstract: The management of acute myocardial infarction continues to undergo major changes. Good practice should be based on sound evidence derived from well-conducted clinical trials. Because of the great number of trials on new treatments performed in recent years and because of new diagnostic tests, the European Society of Cardiology decided that it was opportune to upgrade the 1996 guidelines and appointed a Task …
1,454 citations
TL;DR: In this paper, early hospital care, hospital discharge, and post-hospital discharge care are recommended for Acs, based on myocardial revascularization and initial evaluation and management.
Abstract: Preamble 2356
1. Introduction 2357
2. Overview of Acs 2358
3. Initial Evaluation and Management: Recommendations 2358
4. Early Hospital Care: Recommendations 2363
5. Myocardial Revascularization: Recommendations 2369
6. Late Hospital Care, Hospital Discharge, and Posthospital Discharge Care: Recommendations 2371
1,170 citations
TL;DR: The CRUSADE bleeding score quantifies risk for in-hospital major bleeding across all postadmission treatments, which enhances baseline risk assessment for NSTEMI care.
Abstract: Background— Treatments for non–ST-segment–elevation myocardial infarction (NSTEMI) reduce ischemic events but increase bleeding. Baseline prediction of bleeding risk can complement ischemic risk pr...
1,033 citations
Related Topics (5)
Performance Metrics
| Year | Papers |
|---|---|
| 2025 | 55 |
| 2024 | 85 |
| 2023 | 84 |
| 2022 | 162 |
| 2021 | 114 |
| 2020 | 133 |